1. 17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial. (13th November 2020) Authors: Freyer, G; Pothuri, B; Han, S; Chase, D; Monk, B; Heitz, F; Burger, R; Gaba, L; Van Le, L; Guerra, E; Bender, D; Korach, J; Cloven, N; Churruca, C; Follana, P; DiSilvestro, P; Baurain, JF; Jardon, K; Pisano, C; Peen, U Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 944PQUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset. (23rd October 2018) Authors: Moore, K N; Secord, A A; Geller, M; Miller, D S; Cloven, N G; Fleming, G F; Wahner Hendrickson, A E; Azodi, M; DiSilvestro, P; Oza, A; Cristea, M; Berek, J S; Chan, J K; Rimel, B J; Li, Y; Luptakova, K; Clark, R; Matulonis, U A; Monk, B J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the Phase III SOLO1 trial. (1st November 2019) Authors: Moore, K; Colombo, N; Scambia, G; Kim, B-G; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; González-Martín, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, J; Lowe, ES; Bloomfield, R Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II. (1st November 2019) Authors: Oonk, MHM; Slomovitz, B; Baldwin, P; van Doorn, H; van der Velden, J; de Hullu, J; Slangen, B; Gaarenstroom, K; Vergote, I; Brannstrom, M; van Dorst, E; van Driel, W; Hermans, R; Nunns, D; Widschwendter, M; Nugent, D; Holland, C; DiSilvestro, P; Sharma, A; Mannel, R Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗